Migraine, menopause and hormonal replacement therapy

Cephalalgia

Volumn 20, Issue 3, 2000, Pages 214-221

  Silberstein, S D ^a   De Lignires, B ^b  

^a JEFFERSON HEADACHE CENTER   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACEFYLLINE DROTAVERINE; CONJUGATED ESTROGEN; DIOVAL; ESTRADIOL; ESTRADIOL CIPIONATE; ESTRADIOL VALERATE; ESTRAGARD; ESTRAPEL; ESTRO CYP; ESTROGEN; ESTRONE; ETHINYLESTRADIOL; GESTAGEN; GYNOGEN; HYDROXYPROGESTERONE; HYLUTIN; HYPROGEST; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; ORTHO; PIPERAZINE ESTRONE SULFATE; PROGESTERONE; QUINESTROL; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER RISK; DOSE RESPONSE; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; INJECTION; MENOPAUSE; MIGRAINE; SYMPTOMATOLOGY; THROMBOEMBOLISM;

ANIMALS; BREAST NEOPLASMS; ESTRADIOL CONGENERS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIGRAINE DISORDERS; PROGESTERONE CONGENERS;

EID: 0034454658     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2000.00044.x     Document Type: Article

References (76)

1. Menopause: Endocrinology, consequences of estrogen deficiency, effects of hormonal replacement therapy, treatment regimens
2. Menopause: The aging of multiple pacemakers
3. A longitudinal study of the perimenopausal transition: Altered profiles of steroid and pituitary hormones, SHBG and bone mineral density
4. Overview on menopause
5. The fate of the untreated menopause
6. The physiology and measurement of hot flushes
7. Physiology and treatment of hot flushes
8. Estrogen treatment of postmenopausal women
9. Has HRT come of age?
10. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
11. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
12. Hormone therapy to prevent disease and prolong life in postmenopausal women
13. Hormone replacement therapy and endometrial cancer risk: A metaanalysis
14. Postmenopausal hormone replacement therapy
15. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women
16. The Nurses' Health Study Research Group: Oral contraceptive use and morality during 12 years follow-up
17. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women
18. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women
19. A metaanalysis of the effect of estrogen replacement therapy on the risk of breast cancer
20. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
21. Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association (American Heart Association scientific statement)
22. Estrogen and coronary heart disease in women
23. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
24. Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy
25. Reduced mortality associated with long-term postmenopausal estrogen therapy
26. Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women
27. Postmenopausal hormone therapy and mortality
28. Patient-specific decisions about hormone replacement therapy in postmenopausal women
29. Prior to use of estrogen replacement therapy, are users healthier than nonusers?
30. Estrogen replacement therapy II. A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems
31. The risk of acute myocardial infarction after estrogen and estrogen-progestogen replacement
32. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women
33. A case-control study of myocardial infarction in relation to use of estrogen supplements
34. A study of the association between hormone replacement therapy, smoking and occurrence of myocardial infarction in women
35. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
36. Myocardial infarction and estrogen therapy in postmenopausal women
37. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
38. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
39. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal estrogens
40. Risk of venous thromboembolism in users of hormone replacement therapy
41. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
42. Hormone replacement therapy and heart disease prevention: Experimentation trumps observation
43. The evolution of the Women's Health Initiative: Perspectives from the NIH
44. Pharmacokinetics of estrogen
45. Nonoral routes of estrogen administration
46. Management of the menopause
47. Hormone pellet implantation for the menopause and premenstrual syndrome
48. The role and use of progestogens
49. The use of androgens in the menopause and other gynecic disorders
50. Estrogen, headache and oral contraceptives
51. Postoperative counseling and management: Patient evaluation, informed consent, infection prophylaxis, avoidance of complications
52. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
53. The epidemiology of disabling headache
54. Migraine: A follow-up study of 92 patients
55. Characteristics of headache at menopause: A clinico-epidemiologic study
56. Can one cure migraine in women by inducing menopause? Report on forty-two cases
57. Lasting response to ovariectomy in severe intractable premenstrual syndrome
58. The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome
59. The relationship of headache frequency to hormone use in migraine
60. An evaluation of clinical response to piperazine estrone sulphate ('Harmogen') in menopausal patients
61. Deterioration or onset of migraine under estrogen replacement therapy in the menopause
62. Graded sequential therapy in the menopause: A double-blind study
63. Menopausal headache - Psychogenic or metabolic?
64. Double-blind psychometric studies on the effects of natural estrogens on postmenopausal women
65. Double-blind cross-over study of estrogen replacement therapy
66. Headache and sex hormone therapy
67. Transdermal estrogen
68. Efficacy of transdermal estradiol
69. The symptomatology of progestogen intolerance
70. Target drug delivery in gynecology: The first uterine pass effect
71. Coronary risk and estrogen use in postmenopausal women
72. Use of postmenopausal hormones and risk of myocardial infarction
73. Use of replacement estrogens and the risk of myocardial infarction